CN1 COST-EFFECTIVENESS ANALYSIS OF OXALIPLATIN/5-FU/LV IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN THE UK AND GERMANY
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67203-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)67203-8/fulltext
Section Title :
Section Order :
390
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67203-8&doi=10.1016/S1098-3015(10)67203-8